EPISODE · Feb 17, 2024 · 14 MIN
S5 - E2.2 - After The First MASH Drug Approval, Focus Shifts To Patient Access
from Surfing the MASH Tsunami · host HEP Dynamics LLC
Send us Fan MailLeading patient advocates Jeff McIntyre (Global Liver Institute), Milan Mishkovikj (European Liver Patients Association), Tony Villiotti (NASH kNOWledge) and Wayne Eskridge (Fatty Liver Foundation) join Louise Campbell and Roger Green to discuss what Jeff calls "the second half" - the hard work on coding and patient access that will follow the first MASH drug approval.
Embed this episode
NOW PLAYING
S5 - E2.2 - After The First MASH Drug Approval, Focus Shifts To Patient Access
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.